Corticotropin-releasing factor 1 receptor-mediated mechanisms inhibit colonic hypersensitivity in rats

Neurogastroenterology and Motility

Volumn 17, Issue 3, 2005, Pages 415-422

  Greenwood Van Meerveld, Beverley ^a,e   Johnson, A C ^a   Cochrane, S ^a   Schulkin, J ^b,c   Myers, D A ^d  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^d UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Antalarmin; Colon; Corticotropin releasing factor

Indexed keywords

ANTALARMIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1;

ABDOMINAL WALL MUSCULATURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; COLON DILATATION; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; IRRITABLE COLON; MALE; MUSCLE REFLEX; NONHUMAN; PRIORITY JOURNAL; RAT; STRESS;

ANIMALS; ANXIETY; COLON; COLONIC DISEASES; CORTICOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; IRRITABLE BOWEL SYNDROME; PHYSICAL STIMULATION; PYRIMIDINES; PYRROLES; RATS; RATS, INBRED F344; RATS, INBRED WKY; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; REFLEX; SPECIES SPECIFICITY;

EID: 20044366396     PISSN: 13501925     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2005.00648.x     Document Type: Article

References (53)

1. Mertz H, Naliboff B, Munakata J, Niazi N, Mayer EA. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995; 109: 40-52.
2. Ritchie J. Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome. Gut 1973; 14: 125-32.
3. Whitehead WE, Crowell MD, Robinson JC, Heller BR, Schuster MM. Effects of stressful life events on bowel symptoms: subjects with irritable bowel syndrome compared with subjects without bowel dysfunction. Gut 1992; 33: 825-30.
4. Gunter WD, Shepard JD, Foreman RD, Myers DA, Greenwood-Van Meerveld B. Evidence for visceral hypersensitivity in high-anxiety rats. Physiol Behav 2000; 69: 379-82.
5. Williams CL, Peterson JM, Villar RG, Burks TF. Corticotropin-releasing factor directly mediates colonic responses to stress. Am J Physiol 1987; 253: G582-6.
6. Monnikes H, Schmidt BG, Raybould HE, Tache Y. CRF in the paraventricular nucleus mediates gastric and colonic motor response to restraint stress. Am J Physiol 1992; 262: G137-43.
7. Gue M, Junien JL, Bueno L. Conditioned emotional response in rats enhances colonic motility through the central release of corticotropin-releasing factor. Gastroenterology 1991; 100: 964-70.
8. Martinez V, Wang L, Rivier J, Grigoriadis D, Tache Y. Central CRF, urocortins and stress increase colonic transit via CRF1 receptors while activation of CRF2 receptors delays gastric transit in mice. J Physiol 2004; 556: 221-34.
9. Santos J, Saunders PR, Haussen NP et al. Corticotropin-releasing hormone mimics stress-induced colonic epithelial pathophysiology in the rat. Am J Physiol 1999; 277: G391-9.
10. Saunders PR, Santos J, Haussen NP, Yates D, Groot JA, Perdue MH. Physical and psychological stress in rats enhances colonic epithelial permeability via peripheral CRH. Dig Dis Sci 2002; 47: 208-15.
11. Saunders PR, Maillot C, Million M, Tache Y. Peripheral corticotropin-releasing factor induces diarrhea in rats: role of CRF1 receptor in fecal watery excretion. Eur J Pharmacol 2002; 435: 231-5.
12. Tache Y, Perdue MH. Role of peripheral CRF signaling pathways in stress-related alteration of gut motility and mucosal function. Neurogastroenterol Motil 2004; 16: 137-42.
13. Gue M, Del Rio-Lacheze C, Eutamene H, Theodorou V, Fioramonti J, Bueno L. Stress-induced visceral hypersensitivity to rectal distension in rats: role of CRF and mast cells. Neurogastroenterol Motil 1997; 9: 271-9.
14. Million M, Grigoriadis DE, Sullivan S et al. A novel water-soluble selective CRF1 receptor antagonist, NBI35965, blunts stress-induced visceral hyperalgesia and colonic motor function in rats. Brain Res 2003; 985: 32-42.
15. Tache Y, Martinez V, Wang L, Million M. CRF1 receptor signaling pathways are involved in stress-related alteration of colonic function and viscerosensitivity: implications for irritable bowel syndrome. Br J Pharmacol 2004; 141: 1321-30.
16. Fukudo S, Nomura T, Hongo M. Impact of corticotropin-releasing hormone on gastro-intestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome. Gut 1998; 42: 845-9.
17. Grigoriadis DE, Lovenberg TW, Chalmers DT, Liaw C, De Souze EB. Characterization of corticotropin-releasing factor receptor subtypes. Ann N Y Acad Sci 1996; 780: 60-80.
18. 1 receptor mRNA expression. J Neurosci 1995; 15: 6340-50.
19. Koob GF, Sanna PP, Bloom FE. Neuroscience of addiction. Neuron 1998; 21: 467-76.
20. Nemeroff CB. New vistas in neuropeptide research in neuropsychiatry: focus on corticotropin-releasing factor. Neuropsychopharmacology 1992; 6: 69-75.
21. Dunn AJ, Berridge CW. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses. Brain Res Brain Res Rev 1990; 15: 71-100.
22. Tache Y, Martinez V, Million M, Wang L. Stress and the gastrointestinal tract III. Stress-related alterations of gut motor function: role of brain corticotropin-releasing factor receptors. Am J Physiol 2001; 280: G173-7.
23. Deak T, Nguyen KT, Ehrlich AL et al. The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress. Endocrinology 1999; 140: 79-86.
24. Pare WP. The performance of WKY rats on three tests of emotional behavior. Physiol Behav 1992; 51: 1051-6.
25. Glowa JR, Hansen CT. Differences in responses to an acoustic startle stimulus among forty-six rat strains. Behav Genet 1994; 24: 79-84.
26. De La Garza R II, Mahoney JJ III. A distinct neurochemical profile in WKY rats at baseline and in response to acute stress: implications for animal models of anxiety and depression. Brain Res 2004; 1021: 209-18.
27. Rex A, Sondern U, Voigt JP, Franck S, Fink H. Strain differences in fear-motivated behavior of rats. Pharmacol Biochem Behav 1996; 54: 107-11.
28. Ness TJ, Gebhart GF. Colorectal distension as a noxious visceral stimulus: physiologic and pharmacologie characterization of pseudaffective reflexes in the rat. Brain Res 1988; 450: 153-69.
29. Greenwood-Van Meerveld B, Gibson M, Gunter W, Shepard J, Foreman R, Myers D. Stereotaxic delivery of corticosterone to the amygdala modulates colonic sensitivity in rats. Brain Res 2001; 893: 135-42.
30. Langlois A, Pascaud X, Junien JL, Dahl SG, Riviere PJ. Response heterogeneity of 5-HT3 receptor antagonists in a rat visceral hypersensitivity model. Eur J Pharmacol 1996; 318: 141-4.
31. Plourde V, St-Pierre S, Quirion R. Calcitonin gene-related peptide in viscerosensitive response to colorectal distension in rats. Am J Physiol 1997; 273: G191-6.
32. Habib KE, Weld KP, Rice KC et al. Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates. Proc Natl Acad Sci USA 2000; 97: 6079-84.
33. Gabry KE, Chrousos GP, Rice KC et al. Marked suppression of gastric ulcerogenesis and intestinal responses to stress by a novel class of drugs. Mol Psychiatry 2002; 7: 474-83.
34. Esposito P, Chandler N, Kandere K et al. Corticotrophin-releasing hormone and brain mast cells regulate blood-brain barrier permeability induced by acute stress. J Pharmacol Exp Ther 2002; 303: 1061-6.
35. Bale TL, Picetti R, Contarino A, Koob GF, Vale WW, Lee KF. Mice deficient for both corticotropin-releasing factor receptor 1 (CRFR1) and CRFR2 have an impaired stress response and display sexually dichotomous anxiety-like behavior. J Neurosci 2002; 22: 193-9.
36. Maillot C, Million M, Wei JY, Gauthier A, Tache Y. Peripheral corticotrophin releasing factor and stress-stimulated colonic motor activity involve type 1 receptor in rats. Gastroenterology 2000; 119: 1569-79.
37. Wlk M, Wang CC, Venihaki M et al. Corticotropin-releasing hormone antagonists possess anti-inflammatory effects in the mouse ileum. Gastroenterology 2002; 123: 505-15.
38. Ducottet C, Griebel G, Belzung C. Effects of the selective nonpeptide corticotropin-releasing factor receptor 1 antagonist antalarmin in the chronic mild stress model of depression in mice. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27: 625-31.
39. Schulkin J, Gold PW, McEwen BS. Induction of corticotropin-releasing hormone gene expression by glucocorticoids: implication for understanding the states of fear and anxiety and allostatic load. Psychoneuroendocrinology 1998; 23: 219-43.
40. Shepard JD, Barron KW, Myers DA. Corticosterone delivery to the amygdala increases corticotropin-releasing factor mRNA in the central amygdaloid nucleus and anxiety-like behavior. Brain Res 2000; 861: 288-95.
41. Lechner SM, Curtis AL, Brons R, Valentino RJ. Locus coeruleus activation by colon distention: role of corticotropin-releasing factor and excitatory amino acids. Brain Res 1997; 756: 114-24.
42. Accarino AM, Azpiroz F, Malagelada JR. Selective dysfunction of mechanosensitive intestinal afferents in irritable bowel syndrome. Gastroenterology 1995; 108: 636-43.
43. Cook IJ, Van Eeden A, Collins SM. Patients with irritable bowel syndrome have greater pain tolerance than normal subjects. Gastroenterology 1987; 93: 727-33.
44. Zighelboim J, Talley NJ, Phillips SF, Harmsen WS, Zinsmeister AR. Visceral perception in irritable bowel syndrome. Rectal and gastric responses to distension and serotonin type 3 antagonism. Dig Dis Sci 1995; 40: 819-27.
45. Bouin M, Meunier P, Riberdy-Poitras M, Poitras P. Pain hypersensitivity in patients with functional gastrointestinal disorders: a gastrointestinal- specific defect or a general systemic condition? Dig Dis Sci 2001; 46: 2542-8.
46. Chang L, Mayer EA, Johnson T, Fitzgerald LZ, Naliboff B. Differences in somatic perception in female patients with irritable bowel syndrome with and without fibromyalgia. Pain 2000; 84: 297-307.
47. Mertz H, Naliboff B, Munakata J, Niaz N, Mayer EA. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995; 109: 40-52.
48. Naliboff BD, Munakata J, Fullerton S et al. Evidence for two distinct perceptual alterations in irritable bowel syndrome. Gut 1997; 41: 505-12.
49. Verne GN, Robinson ME, Price DD. Hypersensitivity to visceral and cutaneous pain in the irritable bowel syndrome. Pain 2001; 93: 7-14.
50. Verne GN, Robinson ME, Vase L, Price DD. Reversal of visceral and cutaneous hyperalgesia by local rectal anesthesia in irritable bowel syndrome (IBS) patients. Pain 2003; 105: 223-30.
51. Meller ST, Lewis SJ, Brody MJ, Gebhart GF. Age, strain and anesthetic dependent differences in the nociceptive responses produced by i.v. 5-HT in the rat. Brain Res 1992; 587: 88-94.
52. Fender C, Fujinaga M, Maze M. Strain differences in the antinociceptive effect of nitrous oxide on the tail flick test in rats. Anesth Analg 2000; 90: 195-9.
53. Terner JM, Lomas LM, Smith ES, Barrett AC, Picker MJ. Pharmacogenic analysis of sex differences in opioid antinociception in rats. Pain 2003; 106: 381-91.